DE69621939T2 - Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen - Google Patents

Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen

Info

Publication number
DE69621939T2
DE69621939T2 DE69621939T DE69621939T DE69621939T2 DE 69621939 T2 DE69621939 T2 DE 69621939T2 DE 69621939 T DE69621939 T DE 69621939T DE 69621939 T DE69621939 T DE 69621939T DE 69621939 T2 DE69621939 T2 DE 69621939T2
Authority
DE
Germany
Prior art keywords
pct
combination
prostanderivatives
antibiotics
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69621939T
Other languages
English (en)
Other versions
DE69621939D1 (de
Inventor
Dr Scholz
Dr Weber
Dr Angstwurm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE69621939T priority Critical patent/DE69621939T2/de
Application granted granted Critical
Publication of DE69621939D1 publication Critical patent/DE69621939D1/de
Publication of DE69621939T2 publication Critical patent/DE69621939T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69621939T 1995-08-11 1996-08-06 Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen Expired - Lifetime DE69621939T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69621939T DE69621939T2 (de) 1995-08-11 1996-08-06 Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19530884A DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis
PCT/EP1996/003481 WO1997006806A1 (en) 1995-08-11 1996-08-06 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections
DE69621939T DE69621939T2 (de) 1995-08-11 1996-08-06 Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen

Publications (2)

Publication Number Publication Date
DE69621939D1 DE69621939D1 (de) 2002-07-25
DE69621939T2 true DE69621939T2 (de) 2003-01-09

Family

ID=7770106

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19530884A Expired - Lifetime DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis
DE69621939T Expired - Lifetime DE69621939T2 (de) 1995-08-11 1996-08-06 Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19530884A Expired - Lifetime DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis

Country Status (25)

Country Link
US (1) US6040336A (de)
EP (1) EP0852497B1 (de)
JP (1) JPH11510809A (de)
CN (1) CN1080562C (de)
AT (1) ATE219368T1 (de)
AU (1) AU702706B2 (de)
BR (1) BR9609932A (de)
CA (1) CA2228036A1 (de)
CZ (1) CZ291534B6 (de)
DE (2) DE19530884C2 (de)
DK (1) DK0852497T3 (de)
ES (1) ES2181907T3 (de)
HK (1) HK1015707A1 (de)
HU (1) HUP9802450A3 (de)
IL (1) IL122826A (de)
MX (1) MX9801118A (de)
NO (1) NO316424B1 (de)
PL (1) PL184840B1 (de)
PT (1) PT852497E (de)
RU (1) RU2201232C2 (de)
SK (1) SK284195B6 (de)
TR (1) TR199800128T1 (de)
UA (1) UA54397C2 (de)
WO (1) WO1997006806A1 (de)
ZA (1) ZA966775B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663967B1 (en) * 2000-11-17 2003-12-16 Bryant Rubber Corporation Moldable silicone elastomers having selective primerless adhesion
US8183286B2 (en) * 2006-11-16 2012-05-22 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
EP2803365A1 (de) 2013-05-14 2014-11-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Verwendung von Clonazepam in Verbindung mit Antibiotika bei der Behandlung von bakteriell verursachter Meningitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447802A (en) * 1891-03-10 Irvest williams
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4665088A (en) * 1984-11-14 1987-05-12 The Research Foundation Of State University Of New York (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides
AU595287B2 (en) * 1986-02-18 1990-03-29 Syntex (U.S.A.) Inc. Anti-infective injectable formulations
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
AU699085B2 (en) * 1994-04-21 1998-11-19 Schering Aktiengesellschaft PDE IV inhibitors for treating Multiple Sclerosis

Also Published As

Publication number Publication date
TR199800128T1 (xx) 1998-04-21
HK1015707A1 (en) 1999-10-22
BR9609932A (pt) 1999-06-08
MX9801118A (es) 1998-10-31
PL324884A1 (en) 1998-06-22
ES2181907T3 (es) 2003-03-01
AU6871196A (en) 1997-03-12
NO980568D0 (no) 1998-02-10
ATE219368T1 (de) 2002-07-15
NO980568L (no) 1998-02-10
CN1192684A (zh) 1998-09-09
CZ291534B6 (cs) 2003-03-12
ZA966775B (en) 1997-02-19
UA54397C2 (uk) 2003-03-17
NO316424B1 (no) 2004-01-26
HUP9802450A2 (hu) 1999-02-01
IL122826A (en) 2001-11-25
CN1080562C (zh) 2002-03-13
EP0852497B1 (de) 2002-06-19
PL184840B1 (pl) 2002-12-31
AU702706B2 (en) 1999-03-04
RU2201232C2 (ru) 2003-03-27
DK0852497T3 (da) 2002-08-12
HUP9802450A3 (en) 1999-08-30
US6040336A (en) 2000-03-21
IL122826A0 (en) 1998-08-16
DE69621939D1 (de) 2002-07-25
WO1997006806A1 (en) 1997-02-27
SK15698A3 (en) 1998-06-03
DE19530884A1 (de) 1997-02-20
EP0852497A1 (de) 1998-07-15
DE19530884C2 (de) 1997-07-31
CA2228036A1 (en) 1997-02-27
JPH11510809A (ja) 1999-09-21
PT852497E (pt) 2002-10-31
CZ41498A3 (cs) 1998-09-16
SK284195B6 (sk) 2004-10-05

Similar Documents

Publication Publication Date Title
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
FI951468A (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI964772A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
FI962488A0 (fi) HIV:n proteaasin inhibiittoreita
DK312688D0 (da) Glykkopeptid-antibiotika
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
ATE165101T1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
DE69621939D1 (de) Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen
ATE337002T1 (de) Topische behandlung zur vorbeugung von augeninfektionen
FI874123A (fi) Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter.
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
DE69427116T2 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ECSP972170A (es) Compuestos para el tratamiento de infecciones bacterianas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8330 Complete renunciation